These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 27460684)

  • 1. Nanomedicine approaches in acute lymphoblastic leukemia.
    Tatar AS; Nagy-Simon T; Tomuleasa C; Boca S; Astilean S
    J Control Release; 2016 Sep; 238():123-138. PubMed ID: 27460684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.
    Krishnan V; Rajasekaran AK
    Clin Pharmacol Ther; 2014 Feb; 95(2):168-78. PubMed ID: 24013811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
    Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
    J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain cancer diagnosis and therapy with nanoplatforms.
    Koo YE; Reddy GR; Bhojani M; Schneider R; Philbert MA; Rehemtulla A; Ross BD; Kopelman R
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1556-77. PubMed ID: 17107738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
    Powell AC; Paciotti GF; Libutti SK
    Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia.
    Wu X; Wang F; Yang X; Gong Y; Niu T; Chu B; Qu Y; Qian Z
    Small; 2024 Oct; 20(42):e2403409. PubMed ID: 38934349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotherapeutics for the Treatment of Cancer and Arthritis.
    Patel P; Meghani N; Kansara K; Kumar A
    Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology.
    Miyazawa T; Itaya M; Burdeos GC; Nakagawa K; Miyazawa T
    Int J Nanomedicine; 2021; 16():3937-3999. PubMed ID: 34140768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.